Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 study of MLN0128 (TAK-228) in patients with tumors with TSC1 or TSC2 mutations: Sub-protocol EAY131-M Meeting Abstract

  

Authors:	Hays, J.; Song, Z.; Paik, P.; Iyer, G.; Mitchell, E.; Wright, J.; Doyle, L.; Gray, R.; Wang, V.; McShane, L.; Rubinstein, L.; Patton, D.; Williams, M.; Hamilton, S.; Conley, B.; Arteaga, C.; Harris, L.; O'Dwyer, P.; Chen, A.; Flaherty, K.
Abstract Title:	Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 study of MLN0128 (TAK-228) in patients with tumors with TSC1 or TSC2 mutations: Sub-protocol EAY131-M
Meeting Title:	34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title:	European Journal of Cancer
Volume:	174
Issue:	Suppl. 1
Meeting Dates:	2022 Oct 26-28
Meeting Location:	Barcelona, Spain
ISSN:	0959-8049
Publisher:	Elsevier Inc.
Date Published:	2022-10-01
Start Page:	S25
Language:	English
ACCESSION:	WOS:000876973400061
PROVIDER:	wos
DOI:	10.1016/s0959-8049(22)00870-x
Notes:	Meeting Abstract: 73 -- In Poster Session "Molecular Targeted Agents 1" -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/201265